Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2024-11-29 2024-10-24
Drug Identification Number 02229526 02229526
Brand name APO-DILTIAZ CD APO-DILTIAZ CD
Common or Proper name DILTIAZ CD DILTIAZ CD
Company Name APOTEX INC APOTEX INC
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG 300MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-22 2024-10-22
Estimated end date 2024-12-06 2024-12-06
Actual end date 2024-11-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments